Le Lézard
Classified in: Health
Subjects: RCL, CFG

Food Recall Warning (Allergen) - Olivia & Leo Gourmet Treats brand Dark 55% Cacao Almond Bark recalled due to undeclared milk


Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/olivia-leo-gourmet-treats-brand-dark-55-cacao-almond-bark-recalled-due-undeclared-0

OTTAWA, ON, Dec. 30, 2022 /CNW/ - 

Summary

Affected products

Brand

Product

Size

UPC

Codes

Olivia & Leo
Gourmet Treats

Dark 55% Cacao
Almond Bark

120 g

6 28634 07609 5

BB : 16 JL 2023

Lot : 2321

 

Issue

The affected product is being recalled from the marketplace because it may contain milk which is not declared on the label.

The recalled product has been sold nationally.

What you should do

Learn more:

Background

This recall was triggered by the company.

There have been no reported reactions associated with the consumption of this product.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 05:35
Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1) inhibitor for clinical evaluation in...

at 05:02
'Companion Diagnostics: Technologies and Markets' is all about using special tests alongside certain medicines to figure out which treatment will work best for each person. These tests are called companion diagnostics because they go together with...

at 05:00
WellSync, an API-driven virtual care service provider, today announced its partnership with The Vitamin Shoppe to launch Whole Health Rx, a cutting-edge telehealth service providing access to GLP-1 medications for weight management. WellSync provides...

at 04:00
May 17, 2024 Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs Amsterdam, the Netherlands...

at 04:00
Brainomix, a pioneer in artificial intelligence (AI) imaging solutions to enable precision medicine, is proud to announce the FDA clearance of...

at 04:00
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announced its presence at Heart Rhythm 2024, the Annual Meeting of the Heart Rhythm Society (HRS) in the U.S. At Heart Rhythm 2024, the Company will showcase its upper-arm blood...



News published on and distributed by: